---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-23-001157"
form_type: "8-K"
ticker: "CMPX"
cik: "0001738021"
company_name: "Compass Therapeutics, Inc."
filed_at: "2023-02-24T23:59:59+00:00"
generated_at: "2026-06-19T00:52:22.627032+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Compass Therapeutics board member David Wurzer resigns for personal reasons

## Summary
- David Wurzer resigned from the Board and all committees effective February 20, 2023.
- Resignation was for personal family reasons, not due to any disagreement with the Company.
- No replacement has been announced as of the filing date.

## SEC filing metadata
- accession: 0001171843-23-001157
- form_type: 8-K
- ticker: CMPX
- cik: 0001738021
- company_name: Compass Therapeutics, Inc.
- filed_at: 2023-02-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1738021/000117184323001157/0001171843-23-001157-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1738021/000117184323001157/f8k_022423.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-23-001157
- JSON: https://secwatch.observer/filing/0001171843-23-001157.json
- Plain text: https://secwatch.observer/filing/0001171843-23-001157.txt

## Key facts
- Executive change
  David Wurzer resigned as Director at Compass Therapeutics, Inc..
  - Action: resigned
  - Role: Director
  source text: On February 20, 2023, David Wurzer, a member of the Board of Directors (the “Board”) of Compass Therapeutics, Inc. (the “Company”), notified the Company of his resignation from the Board, and all committees thereof, for personal family reasons effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1738021/000117184323001157/0001171843-23-001157-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.